We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$844M
AUM Growth
-$811M
Cap. Flow
-$843M
Cap. Flow %
-99.83%
Top 10 Hldgs %
29.6%
Holding
364
New
95
Increased
32
Reduced
43
Closed
187

Top Sells

Rank Stock Value
1
JAH
JARDEN CORPORATION
JAH
+$25M
2
XLNX
Xilinx Inc
XLNX
+$20.1M
3
HSY icon
Hershey
HSY
+$17.2M
4
EL icon
Estee Lauder
EL
+$17M
5
ALTR
Altera Corp
ALTR
+$14.7M

Sector Composition

Rank Sector Weight
1 Healthcare 11.12%
2 Industrials 7.29%
3 Technology 6.69%
4 Communication Services 6.15%
5 Consumer Discretionary 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BA icon
76
PUT
Boeing
BA
$167B
$3.55M 0.42%
+27,300
New +$3.46M
EXPR
77
DELISTED
Express, Inc.
EXPR
$3.53M 0.42%
12,000
+9,500
+380% +$2.74M
KRA
78
CALL
DELISTED
Kraton Corporation
KRA
$3.52M 0.42%
+169,500
New +$3.11M
INSY
79
DELISTED
Insys Therapeutics, Inc.
INSY
$3.48M 0.41%
165,000
+17,000
+11% +$336K
BEL
80
DELISTED
Belmond Ltd.
BEL
$3.4M 0.4%
275,000
-209,100
-43% -$2.38M
DSCI
81
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$3.4M 0.4%
+365,000
New +$3.17M
ITB icon
82
iShares US Home Construction ETF
ITB
$2.35B
$3.36M 0.4%
+130,000
New +$3.17M
NWY
83
DELISTED
New York & Co Inc
NWY
$3.36M 0.4%
+1,273,258
New +$3.53M
FOLD
84
DELISTED
Amicus Therapeutics
FOLD
$3.33M 0.39%
+400,000
New +$2.75M
OLN icon
85
CALL
Olin
OLN
$2.49B
$3.14M 0.37%
+137,900
New +$3.36M
RFMD
86
DELISTED
RF MICRO DEVICES INC
RFMD
$2.99M 0.35%
+180,000
New +$2.4M
PRO
87
DELISTED
PROS Holdings
PRO
$2.93M 0.35%
+106,550
New +$2.82M
APD icon
88
PUT
Air Products & Chemicals
APD
$65.2B
$2.88M 0.34%
+21,620
New +$2.73M
CSC
89
PUT
DELISTED
Computer Sciences
CSC
$2.87M 0.34%
+107,972
New +$2.78M
VNDA icon
90
CALL
Vanda Pharmaceuticals
VNDA
$314M
$2.83M 0.33%
197,500
+110,000
+126% +$1.3M
ASRT
91
CALL
DELISTED
Assertio
ASRT
$2.82M 0.33%
+2,917
New +$2.66M
HOG icon
92
Harley-Davidson
HOG
$2.61B
$2.81M 0.33%
42,700
-41,901
-50% -$2.71M
QIHU
93
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
$2.78M 0.33%
+48,500
New +$3.2M
COVS
94
DELISTED
Covisint Corporation
COVS
$2.75M 0.33%
1,037,490
+823,427
+385% +$2.36M
RKT
95
CALL
DELISTED
ROCK-TENN COMPANY CL-A
RKT
$2.74M 0.32%
+45,000
New +$2.44M
CAM
96
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
$2.7M 0.32%
+54,000
New +$2.99M
CFG icon
97
Citizens Financial Group
CFG
$30.1B
$2.69M 0.32%
108,380
-291,620
-73% -$6.95M
T icon
98
PUT
AT&T
T
$167B
$2.69M 0.32%
+106,185
New +$2.76M
BBBY
99
Bed Bath & Beyond
BBBY
$512M
$2.67M 0.32%
+146,410
New +$2.47M
YPF icon
100
CALL
YPF
YPF
$20B
$2.65M 0.31%
+100,000
New +$3.09M

Similar funds

J. Goldman & Co's Q4 2014 Portfolio in Review

As of Q4 2014, J. Goldman & Co held 364 positions worth $844M, down 49% from $1.66B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

J. Goldman & Co withdrew a net $843M in Q4 2014, closing 187 positions and reducing 43 holdings. Its most notable exit was JARDEN CORPORATION, an estimated $25M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 5.6% a quarter earlier, followed by Industrials and Technology.

Against the trend, J. Goldman & Co opened a new position in Wright Medical Group Inc worth $9M.

  • J. Goldman & Co's largest Q4 2014 buy was Wright Medical Group Inc: 335,000 shares worth $9M.
  • J. Goldman & Co added most to Allergan Inc in Q4 2014, an estimated $18.5M increase.
  • J. Goldman & Co's biggest Q4 2014 reduction was Apple, cutting an estimated $14.1M.
  • J. Goldman & Co fully exited JARDEN CORPORATION in Q4 2014, selling an estimated $25M.
  • J. Goldman & Co's ten largest holdings make up 30% of its $844M portfolio in Q4 2014.
  • J. Goldman & Co opened 95 new positions and closed 187 in Q4 2014.
  • J. Goldman & Co's portfolio value fell 49% quarter-over-quarter to $844M.

Based on J. Goldman & Co's 13F filing for Q4 2014, filed 17 Feb 2015.